What our research found
AgelessRx is an active U.S. longevity and telehealth platform operated by AgelessRx, Inc. Its current footer lists an Ann Arbor, Michigan address, phone number, and support email. The company says it began as Qalytude before adopting the AgelessRx name.
The legal terms separate the platform from medical care. AgelessRx supplies technology and administration, Positron Medical Group P.C. provides or coordinates clinical services, licensed clinicians make prescribing decisions, and pharmacies or manufacturer partners fulfill approved prescriptions.
The intake begins online and requires identity verification. A clinician reviews the medical history and proposed treatment. Some states require a video visit, and a clinician may request one in other cases. AgelessRx describes these visits as five to ten minutes and says they add no fee.
The current FAQ says a prescription charge is not collected until clinical approval, including completion of any required video visit. Approval is not guaranteed, and the selected treatment, dose, formulation, or prescription may change after review.
AgelessRx offers more than a typical single-purpose telehealth program. Current in-scope choices include GLP-1 care, metformin, low-dose naltrexone, rapamycin, NAD+, sermorelin, glutathione, daily tadalafil, women's hormones, hair loss, skin prescriptions, and related longevity services.
This review does not convert every product into a therapy card. The normalized cards reuse seven existing active-ingredient records. Provider protocols, doses, route variants, subscription lengths, and branded access services stay under those identities or remain editorial-only.
The GLP-1 catalog separates full-dose and microdose programs. Microdosing semaglutide and tirzepatide use lower individualized doses than standard weight-loss protocols, so their prices are not compared as though they were equivalent to a full-dose program.
Microdosing semaglutide is advertised at a $99 monthly equivalent for an introductory four-month plan billed in full, followed by a $159 monthly equivalent. The page also labels monthly and two-month options but does not publish their exact standard totals. The card therefore shows $159 per month as the stable continuation figure rather than averaging a promotion with renewal.
Microdosing tirzepatide is advertised at $159 per month on a four-month plan billed in full, equal to $636 for the term. The page labels monthly and two-month options without complete public totals. Its compact card shows the disclosed four-month effective rate and remains outside full-dose comparison.
AgelessRx also markets a general injectable GLP-1 program starting at $139 per month. Because the public page does not assign one fixed active ingredient or disclose the complete monthly, two-month, and four-month table, that program remains in the narrative rather than creating another semaglutide or tirzepatide row.
Wegovy and Zepbound require another layer of cost reconstruction. AgelessRx handles consultation and monitoring, while NovoCare, Amazon Pharmacy, or LillyDirect handles medication payment or fulfillment. Catalog starting prices do not clearly reconcile both charges, so the branded programs are not normalized as all-in medication prices.
Metformin is the simplest current price. The public product page lists oral metformin starting at $25 per month and explains that it is commercially available rather than custom compounded. The page does not publish every plan total, so the card uses the current monthly figure without an Avg. label.
Low-dose naltrexone also starts at $25 per month, with monthly, three-month, and six-month plan labels. AgelessRx describes the capsules and clinician-guided titration, but exact term totals are missing and the production catalog has no exact canonical medication match. It remains editorial-only pending a deliberate catalog decision.
Rapamycin starts at $65 per month and includes baseline and ongoing blood work. The provider may offer a generic or compounded product depending on state and clinical circumstances. Those formulations should not be blended, and no current canonical medication match exists, so no card is created.
NAD+ injection is advertised at $79 for an introductory month on a three-month plan and $149 per month afterward. The page says the plan is billed in full but does not present one unambiguous initial invoice or map every price to the 500 mg and 1,000 mg vial choices. The compact card uses the continuation rate and withholds comparison.
Sermorelin has clearer first-term math. AgelessRx lists a $397 first three-month shipment and a $149 monthly continuation rate. The treatment is a compounded subcutaneous injection, but the public page does not establish one concentration or dose that can be assumed across every prescription.
Glutathione injection follows a similar offer pattern: $99 for the introductory month on a three-month plan, then $149 per month. The public page does not show one initial invoice total, so the card uses the continuation figure and does not invent a term average.
Daily tadalafil is the one treatment with two complete comparable standard terms. The standard monthly plan is $70 and the standard quarterly plan is $180, or $60 per month. Their unweighted mean is $65 per month. The $155 introductory quarterly total is a lifecycle promotion and is excluded.
Women's Hormone Care charges a $50 monthly membership plus the selected medication, which starts at $24 per month. Estradiol, progesterone, and DHEA are options, but the route and prescription determine the final cost. Combining the minimum membership and medicine figures would not be a reliable medication comparison.
Powers Hair Solution v5.1 is one topical combination, not a minoxidil-only or dutasteride-only offer. AgelessRx lists those two ingredients plus nine others and charges $95 for the first month, then $120 monthly. The formula remains editorial-only rather than creating separate ingredient cards.
The patient-specific pharmacy is not named before intake. One FAQ answer describes all partners as 503A pharmacies, while a later answer says 503A or 503B. FDA distinguishes those pathways and states that compounded drugs are not FDA approved or reviewed before marketing for safety, effectiveness, or quality.
AgelessRx says subscription shipping is included and estimates delivery in five to seven business days. It says the platform serves all 50 states, but individual treatments vary. Cold-shipped injectables may not be available in Alaska or Hawaii, and some products have additional state exclusions.
The service is cash pay and does not bill insurance. HSA or FSA cards may be accepted, but eligibility is not guaranteed. AgelessRx supplies itemized receipts but says it does not provide letters of medical necessity or complete third-party reimbursement forms.
Subscriptions can be canceled, paused, or postponed before the next refill. The current FAQ asks for at least 48 hours before processing. Refunds are not guaranteed after the pharmacy receives an order, and prescription products cannot be returned or refunded after leaving the pharmacy.
Support routes include 650-503-9990, info@agelessrx.com, the customer portal, provider messaging, and recurring check-ins. AgelessRx does not publish general support hours or a response-time target, so availability should not be described as round-the-clock.
The terms page predates many current treatments and fulfillment relationships. Current product pages and the FAQ provide the more specific commercial facts, but updating the operative terms would make the purchase rules easier to audit.
- Seven reusable active-ingredient cards replace a much larger set of branded programs and route variants.
- Only tadalafil has two comparable standard terms and receives an Avg. $65/mo card.
- Several injectable headlines require a prepaid introduction and renew at a higher monthly rate.
- The platform identifies its medical group but not the patient-specific pharmacy before intake.